Pathophysiology and genetic mutations in congenital sideroblastic anemia

Sideroblastic anemias are heterogeneous congenital and acquired disorders characterized by anemia and the presence of ringed sideroblasts in the bone marrow. Congenital sideroblastic anemia (CSA) is a rare disease caused by mutations of genes involved in heme biosynthesis, iron–sulfur [Fe‐S] cluster biosynthesis, and mitochondrial protein synthesis. The most common form is X‐linked sideroblastic anemia, due to mutations in the erythroid‐specific δ‐aminolevulinate synthase (ALAS2), which is the first enzyme of the heme biosynthesis pathway in erythroid cells. Other known etiologies include mutations in the erythroid specific mitochondrial transporter (SLC25A38), adenosine triphosphate (ATP) binding cassette B7 (ABCB7), glutaredoxin 5 (GLRX5), thiamine transporter SLC19A2, the RNA‐modifying enzyme pseudouridine synthase (PUS1), and mitochondrial tyrosyl‐tRNA synthase (YARS2), as well as mitochondrial DNA deletions. Due to its rarity, however, there have been few systematic pathophysiological and genetic investigations focusing on sideroblastic anemia. Therefore, a nationwide survey of sideroblastic anemia was conducted in Japan to investigate the epidemiology and pathogenesis of this disease. This review will cover the findings of this recent survey and summarize the current understanding of the pathophysiology and genetic mutations involved in CSA.

[1]  J. Tolmie,et al.  Human ABC7 transporter: gene structure and mutation causing X-linked sideroblastic anemia with ataxia with disruption of cytosolic iron-sulfur protein maturation. , 2000, Blood.

[2]  E. Neufeld,et al.  Thiamine-responsive megaloblastic anemia: identification of novel compound heterozygotes and mutation update. , 2009, The Journal of pediatrics.

[3]  V. Tiranti,et al.  Nonsense mutation in pseudouridylate synthase 1 (PUS1) in two brothers affected by myopathy, lactic acidosis and sideroblastic anaemia (MLASA) , 2006, Journal of Medical Genetics.

[4]  V. Tiranti,et al.  Nonsense mutation in pseudouridylate synthase 1 (PUS1) in two brothers affected by myopathy, lactic acidosis and sideroblastic anaemia (MLASA) , 2009, BMJ Case Reports.

[5]  R. Giegé,et al.  Mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia--MLASA syndrome. , 2010, American journal of human genetics.

[6]  C. Beaumont,et al.  Missense SLC25A38 variations play an important role in autosomal recessive inherited sideroblastic anemia , 2011, Haematologica.

[7]  A. Yunis,et al.  Drug-induced mitochondrial damage and sideroblastic change. , 1980, Clinics in haematology.

[8]  T. Bourgeron,et al.  Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome. , 1995, Human molecular genetics.

[9]  E. Shoubridge,et al.  A novel mutation in YARS2 causes myopathy with lactic acidosis and sideroblastic anemia , 2012, Human mutation.

[10]  E. Beutler.  Hereditary and acquired sideroblastic anemias , 1995 .

[11]  S. Shibahara,et al.  Late-onset X-linked sideroblastic anemia following hemodialysis. , 2003, Blood.

[12]  Henriette O'Geen,et al.  Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. , 2009, Molecular cell.

[13]  E. Neufeld,et al.  Systematic molecular genetic analysis of congenital sideroblastic anemia: Evidence for genetic heterogeneity and identification of novel mutations , 2010, Pediatric blood & cancer.

[14]  T. Cox,et al.  X-linked pyridoxine-responsive sideroblastic anemia due to a Thr388-to-Ser substitution in erythroid 5-aminolevulinate synthase. , 1994, The New England journal of medicine.

[15]  S. Ogawa,et al.  Clinical and genetic characteristics of congenital sideroblastic anemia: comparison with myelodysplastic syndrome with ring sideroblast (MDS-RS) , 2012, Annals of Hematology.

[16]  R. Hoffman,et al.  A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. , 1979, The Journal of pediatrics.

[17]  T. Rouault,et al.  Iron-sulfur cluster biogenesis and human disease. , 2008, Trends in genetics : TIG.

[18]  K. Furuyama,et al.  Hereditary sideroblastic anemia: pathophysiology and gene mutations , 2010, International journal of hematology.

[19]  M. Fleming,et al.  Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia , 2009, Nature Genetics.

[20]  Dieter Jahn,et al.  Crystal structure of 5‐aminolevulinate synthase, the first enzyme of heme biosynthesis, and its link to XLSA in humans , 2005, The EMBO journal.

[21]  C. Camaschella.  Hereditary sideroblastic anemias: pathophysiology, diagnosis, and treatment. , 2009, Seminars in hematology.

[22]  S. Shibahara,et al.  Identification of a novel erythroid-specific enhancer for the ALAS2 gene and its loss-of-function mutation which is associated with congenital sideroblastic anemia , 2014, Haematologica.

[23]  K. Furuyama,et al.  Multiple mechanisms for hereditary sideroblastic anemia. , 2002, Cellular and molecular biology.

[24]  Y. Bykhovskaya,et al.  Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). , 2004, American journal of human genetics.

[25]  M. Fleming,et al.  Abcb7, the gene responsible for X-linked sideroblastic anemia with ataxia, is essential for hematopoiesis. , 2007, Blood.

[26]  Timothy Barrett,et al.  Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness , 1999, Nature Genetics.

[27]  D. Williams.  Copper deficiency in humans. , 1983, Seminars in hematology.

[28]  B. Paw,et al.  Deficiency of glutaredoxin 5 reveals Fe–S clusters are required for vertebrate haem synthesis , 2005, Nature.

[29]  Mutation of a Putative Mitochondrial Iron Transporter Gene (ABC7) in X-Linked Sideroblastic Anemia and Ataxia (XLSA/A) , 1999 .

[30]  Kiriko Kaneko,et al.  Heme as a magnificent molecule with multiple missions: heme determines its own fate and governs cellular homeostasis. , 2007, The Tohoku journal of experimental medicine.

[31]  H. Heimpel,et al.  Sideroblastic anemia: molecular analysis of the ALAS2 gene in a series of 29 probands and functional studies of 10 missense mutations , 2011, Human mutation.

[32]  Williams Dm.  Copper deficiency in humans. , 1983 .

[33]  A. Hutchinson,et al.  Mutation of a Putative Mitochondrial Iron Transporter Gene (ABC7) in X-Linked Sideroblastic Anemia and Ataxia (XLSA/A) , 1999, Human molecular genetics.

[34]  M. Fleming.  Congenital sideroblastic anemias: iron and heme lost in mitochondrial translation. , 2011, Hematology. American Society of Hematology. Education Program.

[35]  A. Iolascon,et al.  The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload. , 2007, Blood.

[36]  S. Sassa,et al.  Deficient heme and globin synthesis in embryonic stem cells lacking the erythroid-specific delta-aminolevulinate synthase gene. , 1998, Blood.

[37]  R. Lill,et al.  The mitochondrial proteins Atm1p and Nfs1p are essential for biogenesis of cytosolic Fe/S proteins , 1999, The EMBO journal.

[38]  J. Tisdale,et al.  Glutaredoxin 5 deficiency causes sideroblastic anemia by specifically impairing heme biosynthesis and depleting cytosolic iron in human erythroblasts. , 2010, The Journal of clinical investigation.